Opinion

Canada is not investing enough in dementia research

Leave a Comment

Your email address will not be published. Required fields are marked *

6 Comments
  • DIANE VANALSTYNE says:

    Septa Therapeutics Inc. (www.SeptaTherapeutics.com) has a new approach in Alzheimer’s Disease (AD) research, based on platform technology derived from earlier studies on meningitis. This technology is derived from 15 years in academic neuroscience and 5 years of biotech business experience and has resulted in a new drug candidate for AD treatment. We have a quote from the Charles River contract research organization for US$180,000 for Proof of Concept experiments in mice, to block the onset of AD. We are now raising the funds to complete this highly successful project prior to licensing.
    Septa Therapeutics is a privately held biotech company, with 6 million shares outstanding.

  • Timothy Hudson says:

    More money is needed, yes. And some, perhaps, for research. However, increasing funding to carers directly for respite, increasing education to the medical professionals dealing with cognitive decline and those afflicted by it, and increasing education directly to carers in the community would make an infinitely larger, concrete and immediate difference to the lives of everyone dealing with ALL cognitive decline issues.

    There is a woefully inadequate system in place for the newly diagnosed, and — honestly — there is nothing that indicates a cure to any of the three most common forms of dementia is anywhere on the near-term-horizon: so while working towards a cure is noble, dealing with the immediate effects is infinitely more important.

    As anyone who’s had a loved one suffer from dementia, and witnessed the incomparable burden on the primary carer and any family involved will acknowledge, no amount PR on expensive “promising” research and drug studies could ever compare with having better education about how to deal with these conditions, and navigate the medical system, as well as a few hours of respite regularly from a knowledgeable carer.

    Towards a brighter future with the most effectively distributed funding. Timothy Hudson.

  • D.Bramner says:

    What study is this? I have dementia and would like to participate. Where can I get information?

  • Denyse Lynch says:

    January 25, 2017 PBS AIRED A PROGRAM ON THE ALZHEIMER’S CRISIS … ONE DOCTOR COMMENTED HE DIDN’T UNDERSTAND WHY THE PUBLIC ISN’T IN PANIC OVER THIS EPIDEMIC. IT AFFECTS ALL OF US – HUSBANDS, WIVES, PARTNERS, CHILDREN, GRANDPARENTS, PARENTS, FRIENDS, NEIGHBOURS, RELATIVES, ENEMIES – WHERE IS EVERYONE ? HAVE WE BECOME THE FROG IN THE POT OF WATER THAT IS SLOWLY HEATING UP AND WE JUST HAVE LOST MINDFULNESS?

    • D.Bramner says:

      Hello Dennis
      I have a form of dementia known as reversible. Unfortunately the timeline, when one is a senior, between reversible and death is unattainable. I won’t go into details but the simple answer to your plea for sanity is our health care is rationed. Seniors get the smallest ration. Perhaps you have heard about our talks on ending our lives. This is not idle talk.

Author

Serge Gauthier

Contributor

Dr. Serge Gauthier is Professor of Neurology and Neurosurgery, Psychiatry, and Medicine at McGill University; Director of the Alzheimer Disease and Related Disorders Research Unit, McGill Center for Studies in Aging, Douglas Hospital; and Principal Investigator of Ethical, Legal, and Social Issues in the Canadian Consortium on Neurodegeneration in Aging. Dr. Gauthier was appointed to the Order of Canada in 2015 for his research in Alzheimer’s disease.